Owing to shared risk factors between cardiometabolic diseases(CMDs)and cancer,coupled with population aging,the lifetime risk of an individual developing cancer after a CMD is increasing.Furthermore,biological mechani...Owing to shared risk factors between cardiometabolic diseases(CMDs)and cancer,coupled with population aging,the lifetime risk of an individual developing cancer after a CMD is increasing.Furthermore,biological mechanisms such as insulin resistance or inflammation may not only predispose individuals withCMDto an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage[1,2].展开更多
基金funded by the French National Cancer Institute(INCA_N◦2018-123)and supported by Canccrole Ile-de-France(N◦2018-1-PL SHS-06-CIRC-1)supported by the International Agency for Research on Cancer(IARC)and also by the Department of Epidemiology and Biostatistics,School of Public Health,Imperial College London,which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre(BRC)+9 种基金supported by:Danish Cancer Society(Denmark)Ligue Contre le Cancer,Institut Gustave Roussy,Mutuelle Générale de l’Education Nationale,Institut National de la Santéet de la Recherche Médicale(INSERM)(France)German Cancer Aid,German Cancer Research Center(DKFZ),German Institute of Human Nutrition Potsdam-Rehbruecke(DIfE),Federal Ministry of Education and Research(BMBF)(Germany)Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy,Compagnia di SanPaolo and National Research Council(Italy)Dutch Ministry of Public Health,Welfare and Sports(VWS),Netherlands Cancer Registry(NKR),LK Research Funds,Dutch Prevention Funds,Dutch ZON(Zorg Onderzoek Nederland),World Cancer Research Fund(WCRF),Statistics Netherlands(The Netherlands)Health Research Fund(FIS)-Instituto de Salud Carlos III(ISCIII),Regional Governments ofAndalucía,Asturias,Basque Country,Murcia and Navarra,and the Catalan Institute of Oncology-ICO(Spain)Swedish Cancer Society,Swedish Research Council and County Councils of Skane and Vasterbotten(Sweden)Cancer Research UK(14136 to EPIC-NorfolkC8221/A29017 to EPIC-Oxford),Medical Research Council(1000143 to EPIC-NorfolkMR/M012190/1 to EPIC-Oxford)(United Kingdom).
文摘Owing to shared risk factors between cardiometabolic diseases(CMDs)and cancer,coupled with population aging,the lifetime risk of an individual developing cancer after a CMD is increasing.Furthermore,biological mechanisms such as insulin resistance or inflammation may not only predispose individuals withCMDto an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage[1,2].
